Tyrosine Kinase c-MET as Therapeutic Target for Radiosensitization of Head and Neck Squamous Cell Carcinomas

SIMPLE SUMMARY: The overall five-year survival rate of patients with loco-regional advanced head and neck squamous cell carcinomas (HNSCC) is only around 40%. The curability of HNSCC with radiochemotherapy was previously found to be associated with clinical and biological parameters including tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Lüttich, Lina, Besso, María José, Heiden, Stephan, Koi, Lydia, Baumann, Michael, Krause, Mechthild, Dubrovska, Anna, Linge, Annett, Kurth, Ina, Peitzsch, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070694/
https://www.ncbi.nlm.nih.gov/pubmed/33919702
http://dx.doi.org/10.3390/cancers13081865

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070694/
https://www.ncbi.nlm.nih.gov/pubmed/33919702
http://dx.doi.org/10.3390/cancers13081865

Ejemplares similares